Baohui Han

Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine

SCHOLARLY PAPERS

5

DOWNLOADS

166

TOTAL CITATIONS

1

Scholarly Papers (5)

1.

Toripalimab Plus Chemotherapy for First Line Treatment of Advanced Non-Small Cell Lung Cancer (Choice-01): Final Os and Biomarker Exploration of a Randomized, Double-Blind, Phase 3 Trial

Number of pages: 37 Posted: 02 Aug 2024
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology, Central South University - Thoracic Medicine Department II, Capital Medical University - Beijing Tuberculosis and Thoracic Tumor Research Institute, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology, Jilin Cancer Hospital, China Medical University - Medical Oncology Department of Thoracic Cancer, Guangdong Pharmaceutical University - Department of Medical Oncology, Xuzhou Central Hospital, Jiangnan University - Affiliated Hospital, Chinese Academy of Sciences (CAS) - Key Laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Harbin Medical University, Wenzhou Medical University - Taizhou Hospital of Zhejiang Province, Linyi Cancer Hospital - Department of Medical Oncology, Zhejiang University - Second Affiliated Hospital, The First Affiliated Hospital of Guangxi Medical University, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Tangshan People’s Hospital, Shandong University - Shandong Cancer Hospital, Qingdao Central Hospital, ZhongDa Hospital of Southeast University, Huazhong University of Science and Technology - Department of Medical Oncology, Nanchang University - First Affiliated Hospital, Zhengzhou University - Henan Cancer Hospital, Government of the People's Republic of China - Second People's Hospital of Yibin, Peking University - Department of Thoracic Medical Oncology, Medical School of Nanjing University, Xiamen University - First Affiliated Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Zhengzhou University - Department of Oncology, Xinjiang Medical University - Affiliated Tumor Hospital, China Medical University - Department of Medical Oncology, Qingdao University - Affiliated Hospital, Nanchang University - Department of Medical Oncology, Shandong University - Qilu Hospital, Shanghai Pulmonary Hospital, Tianjin Medical University - Department of Medical Oncology, Nanjing University - Department of Respiratory Medicine, Anhui Provincial Cancer Hospital, Anhui Medical University - Department of Respiratory and Critical Care Medicine, Guangzhou Medical University - Second Affiliated Hospital, Army Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Peking Union Medical College Hospital, Tongji University - Department of Respiratory and Critical Care Medicine, Nantong Tumor Hospital - Department of Medical Oncology, First People's Hospital of Changzhou, Chongqing Medical University - Second Affiliated Hospital, Jilin University (JLU) - Cancer Center, Shanghai Jiao Tong University (SJTU) - Ruijin Hospital of Shanghai, Yangzhou University - Subei People's Hospital of Jiangsu Province, Anhui Provincial Cancer Hospital, Shanxi Provincial People's Hospital, Shanxi Provincial People's Hospital, Chinese Academy of Medical Sciences - Cancer Hospital, Nanjing Medical University - Nanjing First Hospital, Nanjing Medical University - Department of Oncology, ChangZhou Cancer Hospital, Nantong University - Department of Respiratory Medicine, First Hospital of Jiaxing, Fujian Provincial Cancer Hospital, Ground Force Medical University - Xinqiao Hospital, Xi’an Jiaotong University, Health Science Center, First Affiliated Hospital, TopAlliance Biosciences, TopAlliance Biosciences, Burning Rock Biotech - Department of Medicine, Burning Rock Biotech, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), Shanghai Junshi Biosciences Co., LTD, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College - State Key Laboratory of Molecular Oncology
Downloads 45 (823,474)

Abstract:

Loading...

Non-small cell lung cancer, overall survival, immunotherapy, biomarker

2.

mTOR Pathway Gene Mutations Predict Response to Immune Checkpoint Inhibitors in Multiple Cancers

Number of pages: 29 Posted: 17 Jan 2022
Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Fudan University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Fudan University - Shanghai Cancer Center (FUSCC), Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine and Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine
Downloads 37 (888,040)
Citation 1

Abstract:

Loading...

mTOR pathway, Cancer, ICI, TMB, Prognosis

3.

Advanced Non-Small-Cell Lung Cancer Patients with Low Tumor Mutation Burden Might Derive Benefit from Immune Checkpoint Inhibitors

Number of pages: 24 Posted: 28 Sep 2018
Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Fudan University - Shanghai Cancer Center (FUSCC), Fudan University - Zhongshan Hospital, Government of the People's Republic of China - Daping Hospital, Shanghai Applied Protein Technology Co.Ltd (APTBIO), Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Lung Tumor Clinical Medical Center, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital, Shanghai Jiao Tong University (SJTU) - Shanghai Chest Hospital and Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine
Downloads 35 (905,900)

Abstract:

Loading...

non-small cell lung cancer; tumor mutation burden; immune checkpoint inhibitor

4.

Non-Invasive Tumor Immune Dysfunction and Exclusion Evaluation and Chemoimmunotherapy Response Prediction in Lung Adenocarcinoma Using Pathomic-Based Approach

Number of pages: 37 Posted: 15 May 2024
Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Radiology, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine and Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine
Downloads 29 (962,851)

Abstract:

Loading...

Tumor Immune Dysfunction and Exclusion, Lung Adenocarcinoma, Pathomic Model, Chemoimmunotherapy

5.

Different Clinical Characteristics and Survival between Surgically Resected Pure and Combined Small Cell Lung Cancer

Number of pages: 31 Posted: 12 Apr 2022
Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine, Shanghai Jiao Tong University (SJTU) - Department of Respiratory and Critical Care Medicine and Shanghai Jiao Tong University (SJTU) - Department of Pulmonary Medicine
Downloads 20 (1,062,939)

Abstract:

Loading...

Pure small cell lung cancer, Combined small cell lung cancer, Prognosis, Treatment